Cargando…
Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma
The present study was designed to compare the effect of indocyanine green (ICG)-enhanced laser (810 nm) thermocoagulation method and photodynamic therapy (PDT) on circumscribed choroidal hemangioma (CCH). A total of 36 patients (36 pair of eyes) diagnosed with CCH in the Ocular Fundus Disease Center...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844072/ https://www.ncbi.nlm.nih.gov/pubmed/29556306 http://dx.doi.org/10.3892/ol.2018.8056 |
_version_ | 1783305192047902720 |
---|---|
author | Tian, Chuan Chen, Xi Cao, Jin Yang, Lu |
author_facet | Tian, Chuan Chen, Xi Cao, Jin Yang, Lu |
author_sort | Tian, Chuan |
collection | PubMed |
description | The present study was designed to compare the effect of indocyanine green (ICG)-enhanced laser (810 nm) thermocoagulation method and photodynamic therapy (PDT) on circumscribed choroidal hemangioma (CCH). A total of 36 patients (36 pair of eyes) diagnosed with CCH in the Ocular Fundus Disease Center of The Affiliated Hospital of Medical College of Ningbo University from June 2010 to January 2016 were selected and randomly divided into two groups. ICG-enhanced thermocoagulation was used to treat 18 patients (18 pair of eyes), and PDT was used to treat the remaining 18 patients (18 pair of eyes). The best corrected visual acuity of the affected eyes was observed before and after treatment, and changes in the tumor were observed through ocular fundus photochromes under the ophthalmoscope. The changes in tumor size and height were examined through B-scan ultrasonography. The changes in serous retinal fluid were examined by optical coherence tomography (OCT). A total of 36 patients were followed-up for 3, 7, 11 and 24 weeks after laser therapy with an average of 18 weeks. It was seen that the subretinal serous exudation disappeared in 36 patients through the fundus examination after treatment, and B-scan ultrasonography showed that the tumor size was reduced. Among 18 patients undergoing ICG-enhanced thermocoagulation treatment, the visual acuity of 72.2% of them was improved, while that of the remaining 27.8% was stable, and there were no patients with decreased visual acuity; the fundus observation showed that when tumor atrophy occurred, the tumor turned white accompanied with mild pigment disorders, but retinal and choroidal normal vessels were not damaged. Among 18 patients undergoing PDT treatment, the visual acuity of 44.4% was increased, that of 50% was stable, and that of 5.6% of the patients was decreased; through fundus observation, tumor atrophy scars and alignment, a large number of hyperplasia or pigment loss and partial vascular occlusion could be seen. The results indicated that in the treatment of CCH, ICG-enhanced laser (810 nm) thermocoagulation and PDT can lead to tumor atrophy and promote the absorption of exudation. However, the damage of ICG-enhanced laser thermocoagulation to normal fundus tissues is significantly smaller than that of PDT, and the former has higher safety. |
format | Online Article Text |
id | pubmed-5844072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-58440722018-03-19 Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma Tian, Chuan Chen, Xi Cao, Jin Yang, Lu Oncol Lett Articles The present study was designed to compare the effect of indocyanine green (ICG)-enhanced laser (810 nm) thermocoagulation method and photodynamic therapy (PDT) on circumscribed choroidal hemangioma (CCH). A total of 36 patients (36 pair of eyes) diagnosed with CCH in the Ocular Fundus Disease Center of The Affiliated Hospital of Medical College of Ningbo University from June 2010 to January 2016 were selected and randomly divided into two groups. ICG-enhanced thermocoagulation was used to treat 18 patients (18 pair of eyes), and PDT was used to treat the remaining 18 patients (18 pair of eyes). The best corrected visual acuity of the affected eyes was observed before and after treatment, and changes in the tumor were observed through ocular fundus photochromes under the ophthalmoscope. The changes in tumor size and height were examined through B-scan ultrasonography. The changes in serous retinal fluid were examined by optical coherence tomography (OCT). A total of 36 patients were followed-up for 3, 7, 11 and 24 weeks after laser therapy with an average of 18 weeks. It was seen that the subretinal serous exudation disappeared in 36 patients through the fundus examination after treatment, and B-scan ultrasonography showed that the tumor size was reduced. Among 18 patients undergoing ICG-enhanced thermocoagulation treatment, the visual acuity of 72.2% of them was improved, while that of the remaining 27.8% was stable, and there were no patients with decreased visual acuity; the fundus observation showed that when tumor atrophy occurred, the tumor turned white accompanied with mild pigment disorders, but retinal and choroidal normal vessels were not damaged. Among 18 patients undergoing PDT treatment, the visual acuity of 44.4% was increased, that of 50% was stable, and that of 5.6% of the patients was decreased; through fundus observation, tumor atrophy scars and alignment, a large number of hyperplasia or pigment loss and partial vascular occlusion could be seen. The results indicated that in the treatment of CCH, ICG-enhanced laser (810 nm) thermocoagulation and PDT can lead to tumor atrophy and promote the absorption of exudation. However, the damage of ICG-enhanced laser thermocoagulation to normal fundus tissues is significantly smaller than that of PDT, and the former has higher safety. D.A. Spandidos 2018-04 2018-02-15 /pmc/articles/PMC5844072/ /pubmed/29556306 http://dx.doi.org/10.3892/ol.2018.8056 Text en Copyright: © Tian et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Tian, Chuan Chen, Xi Cao, Jin Yang, Lu Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title | Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title_full | Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title_fullStr | Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title_full_unstemmed | Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title_short | Application of ICG-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
title_sort | application of icg-enhanced thermocoagulation method and photodynamic therapy in circumscribed choroidal hemangioma |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844072/ https://www.ncbi.nlm.nih.gov/pubmed/29556306 http://dx.doi.org/10.3892/ol.2018.8056 |
work_keys_str_mv | AT tianchuan applicationoficgenhancedthermocoagulationmethodandphotodynamictherapyincircumscribedchoroidalhemangioma AT chenxi applicationoficgenhancedthermocoagulationmethodandphotodynamictherapyincircumscribedchoroidalhemangioma AT caojin applicationoficgenhancedthermocoagulationmethodandphotodynamictherapyincircumscribedchoroidalhemangioma AT yanglu applicationoficgenhancedthermocoagulationmethodandphotodynamictherapyincircumscribedchoroidalhemangioma |